PATIENTS WITH ACUTE CORONARY SYNDROME, ELEVATED ATHEROGENIC LIPOPROTEINS, AND PRIOR CORONARY ARTERY BYPASS GRAFTING DERIVE LARGE ABSOLUTE BENEFIT FROM ALIROCUMAB: INSIGHTS FROM THE ODYSSEY OUTCOMES TRIAL
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)30639-4
Abstract: Patients (pts) with prior CABG have extensive coronary atherosclerosis and are at increased risk for CV events and death. In the ODYSSEY OUTCOMES trial, 18,924 pts with recent ACS and elevated atherogenic lipoprotein levels (e.g.,… read more here.
Keywords: acute coronary; odyssey outcomes; outcomes trial; patients acute ... See more keywords